0001354488-13-002276.txt : 20130429 0001354488-13-002276.hdr.sgml : 20130427 20130429132555 ACCESSION NUMBER: 0001354488-13-002276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030523 FILED AS OF DATE: 20130429 DATE AS OF CHANGE: 20130429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VILLIGER WALTER CENTRAL INDEX KEY: 0001113655 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 13790475 MAIL ADDRESS: STREET 1: HURDNERSTRASSE 10, POSTFACH 1474 STREET 2: HURDEN CITY: SEITZERLAND STATE: V8 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2003-05-23 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001113655 VILLIGER WALTER PARADIESSTRASSE 25 CH 8645 JONA V8 00000 SWITZERLAND 1 Common Shares 2005-12-31 4 P 0 2360474 0.12 A 2760474 D Common Shares 2006-05-01 4 C 0 2000000 A 4760474 D Common Shares 2006-05-01 4 C 0 5625000 A 10385474 D Common Shares 2006-05-01 4 X 0 1000000 0.04 A 11385474 D Common Shares 2006-05-01 4 X 0 5625000 0.04 A 17010474 D Common Shares 2006-05-01 4 X 0 750000 0.04 A 17760474 D Common Shares 2006-05-01 4 P 0 1062941 0.06 A 18823415 D Common Shares 2007-02-13 4 J 0 416666 0 A 19240081 D Common Share Warrants 0.08 2003-05-23 4 J 0 750000 0 A 2003-05-23 2008-05-23 Common Stock 750000 750000 D Common Share Warrants 0.04 2006-05-01 4 X 0 750000 0 D 2003-05-23 2008-05-23 Common Stock 750000 0 D Series F Preferred Shares 2006-05-01 4 C 0 5000 200.01 D 2001-12-31 Common Stock 2000000 0 D Series F Preferred Warrants 0.04 2006-05-01 4 X 0 2500 200.01 D 2001-12-31 2006-10-31 Common Stock 1000000 0 D Series G Preferred Shares 2006-05-01 4 C 0 18 25000 D 2004-01-13 Common Stock 5625000 0 D Series G Preferred Warrants 0.04 2006-05-01 4 X 0 18 25000 D 2004-01-13 2013-10-31 Common Stock 5625000 0 D Common Share Warrants 0.07 2010-11-29 4 J 0 1000000 0 A 2010-11-29 2015-11-29 Common Shares 1000000 1000000 D Common Share Warrants 0.063 2011-08-10 4 J 0 1000000 0 A 2011-08-10 2016-08-30 Common Shares 1000000 1000000 D Common Share Warrants 0.08 2012-05-30 4 J 0 1000000 0 A 2012-05-30 2017-05-30 Common Shares 1000000 1000000 D On May 23, 2003, the reporting person acquired 750,000 common share purchase warrants from the issuer in connection with the issuance of a 12-month promissory note evidencing a loan from the reporting person to the Issuer. Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares. In March 2006, the Board of Directors approved a plan to raise additional capital from the holders of its outstanding warrants and stock options at a reduced price of $0.04 per share, in order to a) prevent further dilution by the issuance of additional securities to outsiders, and (b) to restructure the capitalization of the Company. On May 1, 2006, the reporting person converted the Series F preferred stock and Series G preferred stock into common shares, and exercised the Series F, Series G and May 23, 2003 warrants for shares of the issuer?s common stock, at an adjusted warrant exercise price of $0.04, to acquire a total of 15,000,000 shares of the company?s common stock. Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer?s common shares. Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010. Series F private placement consisted of units of Series F preferred shares and Series F warrants at a combined price of $200.01 per unit. Series G private placement consisted of units of Series G preferred shares and Series G warrants at a combined price of $25,000 per unit. Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $4,750,000 and extending the maturity date to January 11, 2013. Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,250,000. Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,750,000 and extending the maturity date to January 11, 2016. /s/ WALTER VILLIGER 2013-04-29